Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
Ovarian cancer (OvCa) is a destructive malignancy due to difficulties in early detection and late advanced-stage diagnoses, leading to high morbidity and mortality rates for women. Currently, the quality treatment for OvCa includes tumor debulking surgery and intravenous platinum-based chemotherapy....
Guardado en:
Autores principales: | Melayshia McFadden, Santosh Kumar Singh, Gabriela Oprea-Ilies, Rajesh Singh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/433a7f45acae4b5a9b21636581610603 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Drug delivery approaches for breast cancer
por: Singh SK, et al.
Publicado: (2017) -
Drug delivery
Publicado: (1993) -
Construction of a Multifunctional Nano-Scale Metal-Organic Framework-Based Drug Delivery System for Targeted Cancer Therapy
por: Mengru Cai, et al.
Publicado: (2021) -
Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery
por: Tsolou A, et al.
Publicado: (2020) -
Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery
por: Naz S, et al.
Publicado: (2019)